Unknown

Dataset Information

Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?


ABSTRACT:

SUBMITTER: Harbeck N 

PROVIDER: S-EPMC6048618 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature